Skip to main content

Exelixis, Inc.

EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000939767

In the last 90 days, Exelixis, Inc. insiders filed 0 open-market purchases and 1 sale; 760 institutions reported holding it in 13F filings for Q2 2026, worth $14.1B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Exelixis, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $526.5K in total
Insiders trading
1
Net value
−$526.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Exelixis, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Exelixis, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Beckerle Mary CDirector16,079Aug 12, 20264
Wyszomierski Jack LDirector284,384Jun 3, 20263
Eckhardt Sue GailDirector16,079Jun 3, 20263
Caligan Partners LPDirector, Other: See Remarks1,553,262IndirectMay 29, 20262
Johnson David EdwardDirector1,553,262IndirectMay 29, 20262
Poste GeorgeDirector127,199May 29, 20262
Papadopoulos SteliosDirector1,197,595May 29, 20262
Freire Maria CDirector109,186May 29, 20262
Smith JulieDirector28,957May 29, 20262
Oliver BobDirector29,487May 29, 20263
Heyman Tomas J.Director50,649May 29, 20261
Aftab DanaEVP, Research and Development594,741May 28, 202610
Haley Patrick J.EVP, Commercial357,638May 22, 20266
Morrissey MichaelPresident and CEO2,004,327IndirectMay 19, 20266
Senner Christopher J.EVP and CFO952,317May 19, 20264
Hefti BrendaSVP and General Counsel106,762May 19, 20264
Hessekiel JeffreyEVP & General Counsel693,396May 16, 20250
Peterson Amy C.EVP Prod Dev & Med Aff & CMO465,393May 16, 20250
Garber Alan MDirector35,703Mar 25, 20240
Wright JacquelineDirector51,756Jun 2, 20230
Goodman Vicki LEVP, Prod Dev & Med Aff &CMO307,654Apr 5, 20230
Feldbaum Carl BDirector18,701Feb 10, 20230
Lamb PeterEVP, Scientific Strategy & CSO410,958Dec 16, 20220
Marchesi Vincent TDirector93,989May 27, 20220
Willsey LanceDirector424,415May 27, 20220
Schwab GiselaPres, Prod Dev & Med Aff & CMO689,078Jul 28, 20210
Cohen CharlesDirector261,375Jul 8, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2026 (view filing)7:34 PM ETAug 102 daysBeckerle Mary CDirectorSSale−9.81K$53.66−$526.5K−37.9%16.1K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysWyszomierski Jack LDirectorSSale−3.92K$50.55−$198.4K−1.4%284.4K after10b5-1
Jun 3, 2026 (view filing)Jun 12 daysEckhardt Sue GailDirectorSSale−9.81K$50.14−$492.0K−37.9%16.1K after10b5-1
May 28, 2026 (view filing)May 262 daysAftab DanaEVP, Research and DevelopmentSSale−43.5K$50.35−$2.19M−6.8%594.7K after
May 22, 2026 (view filing)May 202 daysHaley Patrick J.EVP, CommercialSSale−32.1K$49.81−$1.60M−8.2%357.6K after
May 19, 2026 (view filing)May 181 daySenner Christopher J.EVP and CFOSSale−34.9K$50.00−$1.75M−3.5%952.3K after
May 19, 2026 (view filing)May 181 dayHefti BrendaSVP and General CounselSSale−6.63K$50.21−$332.6K−5.8%106.8K after10b5-1
May 8, 2026 (view filing)May 71 dayBeckerle Mary CDirectorSSale−7.71K$48.45−$373.6K−30.6%17.5K after
May 8, 2026 (view filing)May 71 dayFreire Maria CDirectorSSale−20.6K$46.00−$949.2K−17.0%100.8K after
May 8, 2026 (view filing)May 71 dayPoste GeorgeDirectorSSale−60.0K$45.71−$2.74M−33.6%118.8K after
Feb 26, 2026 (view filing)Feb 242 daysAftab DanaEVP, Research and DevelopmentSSale−47.9K$44.50−$2.13M−7.2%616.1K after
Feb 23, 2026 (view filing)Feb 194 daysAftab DanaEVP, Research and DevelopmentSSale−29.9K$44.35−$1.32M−4.3%664.0K after
Feb 20, 2026 (view filing)Feb 182 daysWyszomierski Jack LDirectorSSale−99.6K$44.01−$4.38M−26.2%279.9K after10b5-1
Feb 19, 2026 (view filing)Feb 17-182 daysSmith JulieDirectorSSale−106.5K$44.00−$4.69M−83.8%20.6K after3 lots
Feb 18, 2026 (view filing)Feb 13-175 daysSenner Christopher J.EVP and CFOSSale−64.9K$43.32−$2.81M−6.2%976.1K after2 lots
Feb 18, 2026 (view filing)Feb 171 dayHaley Patrick J.EVP, CommercialSSale−67.8K$43.52−$2.95M−15.1%381.9K after2 lots
Feb 18, 2026 (view filing)Feb 135 daysEckhardt Sue GailDirectorSSale−3.86K$43.79−$168.9K−18.0%17.5K after10b5-1
Feb 18, 2026 (view filing)Feb 135 daysOliver BobDirectorSSale−30.3K$43.81−$1.33M−58.9%21.1K after2 lots
Feb 18, 2026 (view filing)Feb 18Same dayHefti BrendaSVP and General CounselSSale−18.7K$44.01−$821.6K−16.2%96.5K after10b5-1
Nov 26, 2025 (view filing)4:05 PM ETNov 251 dayCaligan Partners LP and 1 otherDirector, Other: See RemarksPPurchase+27.5K$43.12+$1.19M+1.8%1.55M after
Nov 24, 2025 (view filing)Nov 20-214 daysHaley Patrick J.EVP, CommercialSSale−38.0K$42.46−$1.62M−9.2%374.0K after2 lots
Nov 24, 2025 (view filing)Nov 204 daysHaley Patrick J.EVP, CommercialSSale−34.2K$41.88−$1.43M−100.0%0 after2 lots
Nov 13, 2025 (view filing)Nov 121 dayPapadopoulos SteliosDirectorSSale−100.0K$43.55−$4.36M−7.8%1.19M after
Nov 13, 2025 (view filing)Nov 112 daysAftab DanaEVP, Research and DevelopmentSSale−48.4K$42.50−$2.06M−6.8%664.8K after
Nov 13, 2025 (view filing)Nov 112 daysBeckerle Mary CDirectorSSale−24.6K$41.93−$1.03M−53.5%21.4K after2 lots
Jun 4, 2025 (view filing)Jun 22 daysEckhardt Sue GailDirectorSSale−18.8K$42.74−$805.1K−46.8%21.4K after2 lots10b5-1
Jun 4, 2025 (view filing)Jun 31 dayWyszomierski Jack LDirectorSSale−7.54K$43.09−$324.7K−2.1%358.9K after10b5-1
May 22, 2025 (view filing)May 202 daysHaley Patrick J.EVP, CommercialSSale−34.4K$44.06−$1.52M−7.7%412.1K after
May 22, 2025 (view filing)May 211 dayHeyman Tomas J.DirectorSSale−4.54K$44.29−$201.3K−12.3%32.5K after
May 16, 2025 (view filing)May 16Same dayPoste GeorgeDirectorSSale−20.6K$45.99−$949.0K−10.9%169.0K after
May 16, 2025 (view filing)May 16Same daySenner Christopher J.EVP and CFOSSale−100.0K$46.00−$4.60M−9.4%967.8K after
May 16, 2025 (view filing)May 151 dayPapadopoulos SteliosDirectorSSale−36.5K$44.35−$1.62M−2.8%1.28M after2 lots
May 16, 2025 (view filing)May 151 dayHessekiel JeffreyEVP & General CounselSSale−25.0K$46.18−$1.15M−3.5%693.4K after
May 16, 2025 (view filing)May 14-152 daysHaley Patrick J.EVP, CommercialSSale−136.4K$47.58−$6.49M−23.4%446.5K after3 lots10b5-1
May 16, 2025 (view filing)May 16Same dayPeterson Amy C.EVP Prod Dev & Med Aff & CMOSSale−72.8K$45.47−$3.31M−13.5%465.4K after
May 5, 2025 (view filing)May 14 daysAftab DanaCSO/EVP Disc & Trans ResearchSSale−1.51K$39.00−$58.8K−0.2%693.2K after10b5-1
Mar 5, 2025 (view filing)Mar 32 daysHaley Patrick J.EVP, CommercialSSale−10.0K$38.80−$388.0K−2.8%341.0K after10b5-1
Feb 28, 2025 (view filing)Feb 27-281 daySmith JulieDirectorSSale−73.8K$38.00−$2.80M−87.3%10.8K after2 lots
Feb 28, 2025 (view filing)Feb 28Same dayWyszomierski Jack LDirectorSSale−8.77K$37.80−$331.4K−2.4%356.6K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysHaley Patrick J.EVP, CommercialSSale−52.6K$36.98−$1.95M−14.8%303.3K after
Feb 26, 2025 (view filing)Feb 251 dayOliver BobDirectorSSale−18.6K$37.25−$694.6K−35.7%33.5K after
Feb 26, 2025 (view filing)Feb 242 daysAftab DanaCSO/EVP Disc & Trans ResearchSSale−27.0K$36.75−$991.8K−5.0%511.9K after
Feb 26, 2025 (view filing)Feb 242 daysSenner Christopher J.EVP and CFOSSale−29.3K$36.14−$1.06M−3.6%779.6K after
Feb 19, 2025 (view filing)Feb 145 daysBeckerle Mary CDirectorSSale−12.2K$34.88−$425.9K−28.7%30.4K after2 lots
Feb 19, 2025 (view filing)Feb 145 daysPoste GeorgeDirectorSSale−15.9K$34.74−$551.5K−8.6%169.0K after
Feb 19, 2025 (view filing)Feb 145 daysFreire Maria CDirectorSSale−44.1K$34.94−$1.54M−32.6%91.0K after
Feb 19, 2025 (view filing)Feb 145 daysEckhardt Sue GailDirectorSSale−11.6K$35.02−$405.1K−27.6%30.4K after2 lots10b5-1
Dec 2, 2024 (view filing)Nov 293 daysHessekiel JeffreyEVP & General CounselSSale−60.0K$36.67−$2.20M−11.0%486.1K after
Nov 26, 2024 (view filing)Nov 224 daysHaley Patrick J.EVP, CommercialSSale−10.0K$35.27−$352.7K−3.5%278.7K after10b5-1
Nov 19, 2024 (view filing)Nov 181 dayHaley Patrick J.EVP, CommercialSSale−41.6K$34.36−$1.43M−12.6%288.7K after2 lots10b5-1